All In Biotech

Free tool

FAERS Monitor: Premarin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021417 or its brand name (Premarin, Estrogens, Conjugated). Reports on generic versions are filed under their own applications.

Reports

59,171

Serious

41,980

71% of reports

Hospitalization

9,522

Death reported

1,854

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • breast cancer9,643
  • breast cancer female8,869
  • drug ineffective3,442
  • nausea2,413
  • headache2,369
  • pain2,304
  • fatigue2,284
  • off label use2,231
  • dizziness1,686
  • breast cancer metastatic1,682
  • dyspnoea1,661
  • malaise1,616
  • diarrhoea1,564
  • arthralgia1,497
  • anxiety1,447

Reports by year received

View as table
YearReports
20044,156
20053,642
20063,215
20071,686
20083,634
20095,174
20109,123
20112,685
20122,581
20132,149
20142,043
20152,431
20162,530
20171,975
20181,787
20192,160
20202,285
20211,520
20221,402
20231,079
2024856
2025641
2026412

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,994,988 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal8,869176.1171.91,033,158
breast cancer metastaticSignal1,68265.962.690,607
breast cancerSignal9,64340.940.1338,030
anxiety1,4471.81.7530
headache2,3691.31.3214
pain2,3041.31.3198
malaise1,6161.31.2121
arthralgia1,4971.31.293
dizziness1,6861.21.158
nausea2,4131.11.016
dyspnoea1,6611.01.03
fatigue2,2841.01.04
drug ineffective3,4420.90.920
off label use2,2310.90.923
diarrhoea1,5640.90.836

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.